why choose us

First received: May 19, 2023

Clinical Trial: Evaluate the Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Antagonists in Patients With Dry Eye Disease and Asthenopia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Dry Eye

Study Type: OBSERVATIONAL


Official Title: An Investigator-Initiated Phase 2a, Open-Label Study to Evaluate the Safety and Efficacy of CGRP Antagonists in Patients With Dry Eye Disease and Asthenopia

Brief Summary: Safety and Efficacy of Medications for Migraine in Patients with Dry Eye Disease or Asthenopia

Read more